Discover how Temple Lung Center’s innovative clinical trials provide early access to breakthrough treatments and enhanced ...

IPF has an insidious onset. It often presents with persistent dry cough associated with worsening breathlessness and progressive decline in one's exercise capacity. Hemoptysis (coughing up blood) is ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

is a progressive fibrotic lung disease of unknown cause. It remains incurable and has a poor prognosis for many patients, with a median survival of 3-5 years from diagnosis. For more information on ...

Jobs with high IPF mortality ratios differed by sex, but notable categories for both included the public administration industry and health care practitioners and technical occupations, according ...